Jerome Haegeli, group chief economist, Swiss Re Market conditions...
Category:
Pandemic
Latest
Fauci says boosters for all key to U.S. reaching COVID-19 endemic level
Dr. Anthony Fauci "To me, if you want to get to endemic, you have...
Family of non-resident Keralites who died abroad due to COVID-19 eligible for Rs 50k ex-gratia? HC asks state govt
Kochi: Family of non-resident Keralites who died abroad due to...
India reports 14,989 fresh COVID-19 cases
As per the Indian Council of Medical Research (ICMR), as many as 21,84,03,277 samples have been tested for the coronavirus as of Tuesday, including 7,85,220 in the last 24 hours.
People can get vaccinated against Covid-19 24×7, says Harsh Vardhan
“The government has lifted the time restriction to increase the speed of vaccination. People can now get vaccinated 24×7 according to their convenience. Prime Minister Narendra Modi understands the value of health as well as the time of citizens,” Vardhan tweeted.
The next phase of the COVID-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions.
Bharat Biotech’s COVID-19 shot 81% effective,Modi’s ministers choose it over AstraZeneca
Many state officials and doctors have refused to take COVAXIN before its effectiveness could be proved. Bharat Biotech says it has completed the late-stage trial and results will be out this month.
“COVAXIN demonstrates high clinical efficacy trend against COVID-19 but also significant immunogenicity against the rapidly emerging variants,” Bharat Biotech Chairman Krishna Ella said in a statement, referring to its vaccine.
Insurer Hiscox counts cost of virus claims, ‘brand damage’ after court case
“Hiscox has undoubtedly suffered some brand damage this year,” the company said
The company lost a high-profile court case in January over the policy wordings and has reserved $475 million for pandemic-linked claims.
Event cancellation and abandonment is expected to account for the biggest share of claims, followed by business interruption, the company said.
UK business interruption insurance anguish far from over
The Financial Conduct Authority (FCA) said the case could affect 370,000 policyholders and 60 insurers, with the potential for billions of pounds in claims.
Many small businesses had policies that enabled them to claim a maximum of 50,000-100,000 pounds for disruption caused by the pandemic and subsequent lockdowns.
India’s present overall case positivity rate suggests COVID-19 close to being under control
Addressing a weekly press conference, Union Health Secretary Rajesh Bhushan said though certain states, including Maharashtra, Kerala, Tamil Nadu, Punjab, Gujarat and Madhya Pradesh, are seeing a surge in number of COVID-19 active cases, ”the fact remains that recovered cases are still more than 97 per cent and India’s total active cases are less than 2 per cent (1.51 per cent)”. Bhushan said that central teams have been deputed to Maharashtra, Tamil Nadu, Punjab, Gujarat and Madhya Pradesh.
India reports 15,510 new COVID-19 cases, 106 deaths
Prime Minister Narendra Modi on Monday took the first dose of Covaxin, India’s homegrown coronavirus vaccine developed by biotechnology firm Bharat Biotech and the Indian Council of Medical Research, addressing hesitancy over the COVID-19 vaccine.
Less than 10 pc of world’s population have coronavirus antibodies: WHO Chief scientist
The only way to achieve mass herd immunity is through vaccination, the WHO chief scientist stressed.
According to Swaminathan, the currently approved vaccines offer good protection against severe disease, hospitalization and death from COVID-19. The vaccines’ effectiveness with regard to mild disease and asymptomatic coronavirus infection is still being studied.
U.S. authorizes Johnson & Johnson’s COVID-19 vaccine
The single-shot vaccine is highly effective in preventing severe Covid-19, including against newer variants, the Food and Drug Administration (FDA) said before giving it a green light.
COVID-19 crisis far from over; 3rd wave to be more dangerous: CSIR officia
Cautioning the people and the scientific community against allowing “complacency to set in,” he warned that a third wave would precipitate a far more dangerous situation than the challenge the country had faced so far.